FDA panel unanimously backs Moderna’s Covid vaccine for children ages 6 to 17
A panel of experts convened by the Food and Drug Administration voted unanimously Tuesday to recommend the agency authorize the Moderna Covid vaccine for children aged 6 to 17.
The authorization would mirror the current emergency use authorization of the Covid vaccine developed by Pfizer and BioNTech, which is authorized for individuals 6 and over.
